Search Orphan Drug Designations and Approvals
-
| Generic Name: | clazakizumab |
|---|---|
| Date Designated: | 08/08/2019 |
| Orphan Designation: | Treatment of chronic antibody-mediated rejection in kidney transplant recipients |
| Orphan Designation Status: | Designated |
| FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
| Sponsor: |
CSL Behring 1020 First Avenue P.O. Box 61501 King of Prussia, Pennsylvania 19406 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
-
